| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.559 | 0.003 | 0.637 | Poly(ADP-ribose) polymerase inhibitor | 0.637 0.002 CHEMBL3527002 0.532 0.003 CHEMBL3542410 0.436 0.004 CHEMBL3527001 | CHEMBL3527002 | |
| 0.507 | 0.003 | 0.58 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.58 0.003 CHEMBL3527002 0.475 0.003 CHEMBL3542410 0.369 0.004 CHEMBL3527001 | CHEMBL3527002 | |
| 0.424 | 0.013 | 0.424 | Cyclic AMP phosphodiesterase inhibitor | 0.297 0.043 CHEMBL3527002 0.306 0.039 CHEMBL3542410 0.365 0.022 CHEMBL3527001 | ||
| 0.359 | 0.05 | 0.527 | Spasmolytic | 0.226 0.102 CHEMBL3527002 0.233 0.099 CHEMBL3542410 0.527 0.02 CHEMBL3527001 | CHEMBL3527001 | |
| 0.366 | 0.08 | 0.395 | MAP kinase kinase 6 inhibitor | 0.395 0.062 CHEMBL3527002 0.372 0.076 CHEMBL3542410 | CHEMBL3527002 | |
| 0.355 | 0.097 | 0.403 | Histamine release inhibitor | 0.304 0.121 CHEMBL3527002 0.403 0.074 CHEMBL3527001 | CHEMBL3527001 | |
| 0.328 | 0.084 | 0.394 | Vasodilator, peripheral | 0.221 0.153 CHEMBL3527002 0.394 0.057 CHEMBL3527001 | CHEMBL3527001 | |
| 0.298 | 0.081 | 0.298 | Sodium/bile acid cotransporter inhibitor | 0.282 0.096 CHEMBL3527001 | ||
| 0.274 | 0.058 | 0.364 | Vasodilator | 0.191 0.112 CHEMBL3527002 0.21 0.097 CHEMBL3542410 0.364 0.03 CHEMBL3527001 | CHEMBL3527001 | |
| 0.262 | 0.051 | 0.274 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.274 0.041 CHEMBL3527002 0.262 0.052 CHEMBL3542410 | CHEMBL3527002 | |
| 0.208 | 0.007 | 0.234 | Phosphodiesterase 3A inhibitor | 0.234 0.005 CHEMBL3527002 0.173 0.012 CHEMBL3542410 0.094 0.038 CHEMBL3527001 | CHEMBL3527002 | |
| 0.22 | 0.029 | 0.22 | Heat shock protein 90 antagonist | 0.142 0.082 CHEMBL3527002 | ||
| 0.288 | 0.098 | 0.443 | Vasodilator, coronary | 0.224 0.16 CHEMBL3542410 0.443 0.024 CHEMBL3527001 | CHEMBL3527001 | |
| 0.188 | 0.01 | 0.188 | Check point kinase 1 inhibitor | 0.18 0.011 CHEMBL3527002 0.124 0.019 CHEMBL3542410 0.106 0.026 CHEMBL3527001 | ||
| 0.181 | 0.015 | 0.181 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.168 0.017 CHEMBL3527002 0.113 0.03 CHEMBL3542410 0.099 0.035 CHEMBL3527001 | ||
| 0.245 | 0.086 | 0.321 | Cardiotonic | 0.206 0.113 CHEMBL3527002 0.321 0.048 CHEMBL3527001 | CHEMBL3527001 | |
| 0.226 | 0.077 | 0.233 | MAP-kinase-activated kinase 5 inhibitor | 0.233 0.071 CHEMBL3527002 0.223 0.079 CHEMBL3542410 | CHEMBL3527002 | |
| 0.176 | 0.03 | 0.182 | MAP3K9 inhibitor | 0.182 0.025 CHEMBL3527002 0.171 0.034 CHEMBL3542410 0.176 0.03 CHEMBL3527001 | CHEMBL3527002 | |
| 0.189 | 0.044 | 0.189 | Cyclin-dependent kinase 8 inhibitor | 0.128 0.106 CHEMBL3527002 | ||
| 0.141 | 0.005 | 0.391 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.391 0.003 CHEMBL3527002 0.096 0.005 CHEMBL3542410 0.041 0.011 CHEMBL3527001 | CHEMBL3527002 | |
| 0.215 | 0.085 | 0.232 | MAP kinase kinase 3 inhibitor | 0.232 0.053 CHEMBL3527002 0.192 0.146 CHEMBL3542410 | CHEMBL3527002 | |
| 0.154 | 0.028 | 0.171 | DNA repair enzyme inhibitor | 0.146 0.035 CHEMBL3527002 0.155 0.027 CHEMBL3542410 0.171 0.017 CHEMBL3527001 | CHEMBL3527001 | |
| 0.136 | 0.012 | 0.154 | Phosphodiesterase III inhibitor | 0.154 0.01 CHEMBL3527002 0.122 0.015 CHEMBL3542410 0.088 0.029 CHEMBL3527001 | CHEMBL3527002 | |
| 0.145 | 0.032 | 0.145 | AMP-activated protein kinase stimulant | |||
| 0.289 | 0.178 | 0.324 | 5 Hydroxytryptamine release inhibitor | 0.324 0.139 CHEMBL3527002 0.245 0.235 CHEMBL3542410 0.243 0.238 CHEMBL3527001 | CHEMBL3527002 | |
| 0.131 | 0.029 | 0.156 | Phosphodiesterase IV inhibitor | 0.156 0.021 CHEMBL3527002 | CHEMBL3527002 | |
| 0.155 | 0.053 | 0.155 | MAP kinase kinase 4 inhibitor | |||
| 0.131 | 0.033 | 0.145 | Creatine kinase inhibitor | 0.107 0.052 CHEMBL3527002 0.145 0.026 CHEMBL3527001 | CHEMBL3527001 | |
| 0.095 | 0.012 | 0.097 | Phosphodiesterase 3B inhibitor | 0.097 0.012 CHEMBL3527002 0.046 0.029 CHEMBL3542410 0.045 0.03 CHEMBL3527001 | CHEMBL3527002 | |
| 0.193 | 0.116 | 0.232 | Tumour necrosis factor alpha release inhibitor | 0.232 0.084 CHEMBL3527002 0.171 0.133 CHEMBL3527001 | CHEMBL3527002 | |
| 0.175 | 0.099 | 0.175 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.163 | 0.091 | 0.163 | TRKC antagonist | |||
| 0.224 | 0.152 | 0.243 | Apoptosis antagonist | 0.243 0.134 CHEMBL3527001 | CHEMBL3527001 | |
| 0.222 | 0.152 | 0.269 | Antithrombotic | 0.269 0.112 CHEMBL3527001 | CHEMBL3527001 | |
| 0.124 | 0.053 | 0.124 | Transcription factor STAT6 inhibitor | |||
| 0.283 | 0.214 | 0.283 | Caspase 9 stimulant | 0.268 0.232 CHEMBL3527001 | ||
| 0.157 | 0.091 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.164 0.078 CHEMBL3527002 | CHEMBL3527002 | |
| 0.181 | 0.116 | 0.349 | Platelet antagonist | 0.349 0.038 CHEMBL3527001 | CHEMBL3527001 | |
| 0.133 | 0.069 | 0.141 | NADPH oxidase inhibitor | 0.141 0.061 CHEMBL3527002 0.113 0.092 CHEMBL3542410 | CHEMBL3527002 | |
| 0.159 | 0.097 | 0.176 | Platelet adhesion inhibitor | 0.176 0.084 CHEMBL3527001 | CHEMBL3527001 | |
| 0.119 | 0.058 | 0.119 | Estrogen antagonist | |||
| 0.212 | 0.152 | 0.222 | Caspase 3 stimulant | 0.212 0.153 CHEMBL3542410 0.222 0.14 CHEMBL3527001 | CHEMBL3527001 | |
| 0.109 | 0.054 | 0.109 | Bronchodilator | 0.089 0.076 CHEMBL3527002 | ||
| 0.085 | 0.031 | 0.085 | MAP kinase kinase 8 inhibitor | |||
| 0.1 | 0.05 | 0.1 | Protein kinase C zeta inhibitor | |||
| 0.087 | 0.038 | 0.087 | Estrogen receptor alpha antagonist | |||
| 0.07 | 0.025 | 0.07 | Sphingosine kinase inhibitor | |||
| 0.08 | 0.036 | 0.08 | CDC7 inhibitor | 0.062 0.054 CHEMBL3527002 | ||
| 0.261 | 0.22 | 0.445 | MAP kinase 1 inhibitor | 0.445 0.08 CHEMBL3527002 0.313 0.167 CHEMBL3542410 | CHEMBL3527002 | |
| 0.117 | 0.081 | 0.166 | Acetylcholinesterase inhibitor | 0.166 0.046 CHEMBL3527002 0.117 0.081 CHEMBL3527001 | CHEMBL3527002 | |
| 0.087 | 0.052 | 0.092 | mTOR complex 2 inhibitor | 0.088 0.05 CHEMBL3527002 0.092 0.043 CHEMBL3542410 | CHEMBL3542410 | |
| 0.1 | 0.065 | 0.1 | Estrogen receptor beta antagonist | |||
| 0.116 | 0.085 | 0.116 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.072 | 0.043 | 0.072 | Protein kinase C beta inhibitor | 0.069 0.05 CHEMBL3542410 | ||
| 0.048 | 0.018 | 0.048 | Acid-sensing ion channel blocker | |||
| 0.079 | 0.05 | 0.079 | MAP kinase kinase 7 inhibitor | |||
| 0.076 | 0.048 | 0.081 | Protein kinase B beta inhibitor | 0.081 0.042 CHEMBL3527002 | CHEMBL3527002 | |
| 0.134 | 0.106 | 0.134 | Heat shock protein 90 alpha antagonist | |||
| 0.27 | 0.245 | 0.27 | Antiinflammatory | |||
| 0.046 | 0.021 | 0.046 | Sphingosine kinase 1 inhibitor | |||
| 0.146 | 0.124 | 0.218 | I kappa B kinase epsilon inhibitor | 0.218 0.057 CHEMBL3527002 | CHEMBL3527002 | |
| 0.241 | 0.224 | 0.38 | Apoptosis agonist | 0.38 0.123 CHEMBL3542410 | CHEMBL3542410 | |
| 0.069 | 0.053 | 0.079 | Telomerase inhibitor | 0.079 0.045 CHEMBL3527002 | CHEMBL3527002 | |
| 0.187 | 0.173 | 0.187 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.162 | 0.151 | 0.185 | Antioxidant | 0.185 0.127 CHEMBL3527001 | CHEMBL3527001 | |
| 0.083 | 0.072 | 0.092 | Protein kinase C delta inhibitor | 0.092 0.06 CHEMBL3542410 | CHEMBL3542410 | |
| 0.068 | 0.059 | 0.079 | Rho-associated kinase II inhibitor | 0.079 0.046 CHEMBL3527002 | CHEMBL3527002 | |
| 0.056 | 0.047 | 0.056 | Heat shock protein 90 beta antagonist | |||
| 0.081 | 0.074 | 0.081 | Pim-3 kinase inhibitor | |||
| 0.137 | 0.132 | 0.147 | Cyclin-dependent kinase 3 inhibitor | 0.146 0.106 CHEMBL3527002 0.147 0.103 CHEMBL3527001 | CHEMBL3527001 | |
| 0.06 | 0.056 | 0.087 | Phosphodiesterase 4B inhibitor | 0.087 0.032 CHEMBL3527002 | CHEMBL3527002 | |
| 0.116 | 0.113 | 0.168 | Cholinergic | 0.168 0.063 CHEMBL3527002 | CHEMBL3527002 | |
| 0.125 | 0.13 | 0.248 | Amyloid beta aggregation inhibitor | 0.248 0.058 CHEMBL3527001 | CHEMBL3527001 | |
| 0.091 | 0.095 | 0.093 | Protein kinase C gamma inhibitor | 0.093 0.09 CHEMBL3542410 | CHEMBL3542410 | |
| 0.031 | 0.042 | 0.047 | DNA-dependent protein kinase inhibitor | 0.038 0.031 CHEMBL3527002 0.047 0.024 CHEMBL3542410 | CHEMBL3542410 | |
| 0.081 | 0.104 | 0.118 | Glycogen synthase kinase-3 beta inhibitor | 0.118 0.063 CHEMBL3527002 | CHEMBL3527002 | |
| 0.083 | 0.107 | 0.112 | mTOR complex 1 inhibitor | 0.112 0.039 CHEMBL3527002 0.107 0.049 CHEMBL3542410 | CHEMBL3527002 | |
| 0.025 | 0.051 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.029 CHEMBL3527001 | CHEMBL3527001 | |
| 0.077 | 0.107 | 0.118 | Polo-like kinase-4 inhibitor | 0.118 0.058 CHEMBL3527002 | CHEMBL3527002 | |
| 0.035 | 0.066 | 0.048 | Dopamine D4 agonist | 0.048 0.037 CHEMBL3527002 | CHEMBL3527002 | |
| 0.075 | 0.109 | 0.115 | Glycogen synthase kinase-3 inhibitor | 0.115 0.065 CHEMBL3527002 | CHEMBL3527002 | |
| 0.059 | 0.098 | 0.141 | MAO B inhibitor | 0.122 0.05 CHEMBL3527002 0.141 0.04 CHEMBL3542410 0.11 0.055 CHEMBL3527001 | CHEMBL3542410 | |
| 0.078 | 0.118 | 0.23 | MAO inhibitor | 0.23 0.033 CHEMBL3527002 0.171 0.051 CHEMBL3542410 0.161 0.056 CHEMBL3527001 | CHEMBL3527002 | |
| 0.032 | 0.072 | 0.102 | Dopamine D4 antagonist | 0.102 0.025 CHEMBL3527002 | CHEMBL3527002 | |
| 0.035 | 0.075 | 0.068 | Phosphodiesterase 4C inhibitor | 0.068 0.028 CHEMBL3527002 | CHEMBL3527002 | |
| 0.048 | 0.09 | 0.083 | Phosphodiesterase 4D inhibitor | 0.083 0.045 CHEMBL3527002 | CHEMBL3527002 | |
| 0.073 | 0.119 | 0.1 | Topoisomerase II inhibitor | 0.1 0.086 CHEMBL3542410 0.096 0.09 CHEMBL3527001 | CHEMBL3542410 | |
| 0.092 | 0.147 | 0.108 | Sphingosine 1-phosphate receptor 4 antagonist | 0.108 0.099 CHEMBL3527002 | CHEMBL3527002 | |
| 0.025 | 0.084 | 0.044 | Phosphodiesterase 4A inhibitor | 0.044 0.04 CHEMBL3527002 | CHEMBL3527002 | |
| 0.117 | 0.177 | 0.158 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.158 0.124 CHEMBL3527002 | CHEMBL3527002 | |
| 0.113 | 0.174 | 0.302 | Antimitotic | 0.302 0.043 CHEMBL3542410 | CHEMBL3542410 | |
| 0.058 | 0.123 | 0.156 | Topoisomerase I inhibitor | 0.156 0.039 CHEMBL3542410 | CHEMBL3542410 | |
| 0.113 | 0.189 | 0.151 | Dyrk kinase inhibitor | 0.151 0.135 CHEMBL3527002 | CHEMBL3527002 | |
| 0.048 | 0.131 | 0.139 | MAO A inhibitor | 0.139 0.045 CHEMBL3527002 0.101 0.063 CHEMBL3542410 0.085 0.076 CHEMBL3527001 | CHEMBL3527002 | |
| 0.148 | 0.233 | 0.177 | Neuropeptide Y2 antagonist | 0.177 0.167 CHEMBL3527002 | CHEMBL3527002 | |
| 0.086 | 0.174 | 0.128 | Protein-tyrosine phosphatase inhibitor | 0.128 0.104 CHEMBL3527001 | CHEMBL3527001 | |
| 0.074 | 0.168 | 0.117 | Alkaline phosphatase inhibitor | 0.117 0.089 CHEMBL3527002 | CHEMBL3527002 | |
| 0.228 | 0.326 | 0.282 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.282 0.238 CHEMBL3527002 | CHEMBL3527002 | |
| 0.055 | 0.156 | 0.133 | ATPase (Vacuolar H+) inhibitor | 0.133 0.013 CHEMBL3542410 | CHEMBL3542410 | |
| 0.039 | 0.139 | 0.082 | Topoisomerase II alpha inhibitor | 0.082 0.051 CHEMBL3527001 | CHEMBL3527001 | |
| 0.103 | 0.215 | 0.159 | 3C-like protease (Human coronavirus) inhibitor | 0.143 0.114 CHEMBL3527002 0.159 0.088 CHEMBL3542410 | CHEMBL3542410 | |
| 0.051 | 0.171 | 0.107 | DNA intercalator | 0.107 0.067 CHEMBL3542410 | CHEMBL3542410 | |
| 0.039 | 0.159 | 0.062 | Potassium channel large-conductance Ca-activated activator | 0.062 0.056 CHEMBL3527001 | CHEMBL3527001 | |
| 0.121 | 0.245 | 0.157 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.157 0.133 CHEMBL3527001 | CHEMBL3527001 | |
| 0.095 | 0.228 | 0.22 | Platelet aggregation inhibitor | 0.22 0.068 CHEMBL3527001 | CHEMBL3527001 | |
| 0.029 | 0.172 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | 0.056 0.031 CHEMBL3527001 | CHEMBL3527001 | |
| 0.089 | 0.233 | 0.155 | Tumour necrosis factor antagonist | 0.155 0.095 CHEMBL3527002 | CHEMBL3527002 | |
| 0.056 | 0.216 | 0.082 | Hematopoietic | 0.082 0.068 CHEMBL3527001 | CHEMBL3527001 | |
| 0.046 | 0.209 | 0.093 | 5 Hydroxytryptamine 3A agonist | 0.093 0.085 CHEMBL3527002 | CHEMBL3527002 | |
| 0.055 | 0.239 | 0.125 | Cytokine production inhibitor | 0.125 0.084 CHEMBL3527001 | CHEMBL3527001 | |
| 0.09 | 0.278 | 0.139 | Lipocortins synthesis antagonist | 0.139 0.123 CHEMBL3527001 | CHEMBL3527001 | |
| 0.005 | 0.203 | 0.032 | Sphingosine 1-phosphate receptor 3 agonist | 0.032 0.026 CHEMBL3527001 | CHEMBL3527001 | |
| 0.067 | 0.266 | 0.134 | Dual specificity phosphatase inhibitor | 0.134 0.114 CHEMBL3527001 | CHEMBL3527001 | |
| 0.038 | 0.242 | 0.083 | Antineoplastic alkaloid | 0.083 0.062 CHEMBL3542410 | CHEMBL3542410 | |
| 0.008 | 0.214 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.035 CHEMBL3527001 | CHEMBL3527001 | |
| 0.038 | 0.261 | 0.132 | Chelator | 0.132 0.044 CHEMBL3527001 | CHEMBL3527001 | |
| 0.011 | 0.263 | 0.042 | Sphingosine 1-phosphate receptor agonist | 0.042 0.034 CHEMBL3527001 | CHEMBL3527001 | |
| 0.041 | 0.323 | 0.095 | Interleukin 5 antagonist | 0.095 0.047 CHEMBL3527001 | CHEMBL3527001 | |
| 0.041 | 0.332 | 0.091 | ABCA1 expression enhancer | 0.091 0.064 CHEMBL3527001 | CHEMBL3527001 | |
| 0.058 | 0.384 | 0.143 | Succinate dehydrogenase inhibitor | 0.143 0.125 CHEMBL3527001 | CHEMBL3527001 | |
| 0.014 | 0.425 | 0.061 | NMDA receptor agonist | 0.061 0.046 CHEMBL3527001 | CHEMBL3527001 | |
| 0.057 | 0.565 | 0.249 | Insulysin inhibitor | 0.249 0.097 CHEMBL3527001 | CHEMBL3527001 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |